Sigilon Therapeutics uses 8 technology products and services including NetSuite, Exhibit, jQuery, and more. Explore Sigilon Therapeutics's tech stack below.
| Sigilon Therapeutics Email Formats | Percentage |
| First.Last@sigilon.com | 85% |
| FLast@sigilon.com | 13% |
| First@sigilon.com | 2% |
Biotechnology ResearchMassachusetts, United States51-200 Employees
Sigilon Therapeutics', a wholly owned subsidiary of Eli Lilly and Company, mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases. We're based in Cambridge, Mass.
Company Overview
Media & News
Funding & FinancialsSigilon Therapeutics has raised a total of $145M of funding over 4 rounds. Their latest funding round was raised on Dec 03, 2020 in the amount of $145M.
Sigilon Therapeutics's revenue is in the range of $10M$50M
Funding & FinancialsSigilon Therapeutics has raised a total of $145M of funding over 4 rounds. Their latest funding round was raised on Dec 03, 2020 in the amount of $145M.
Sigilon Therapeutics's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com